The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment

Detalhes bibliográficos
Autor(a) principal: Silva, Erika Klingelfus de Almeida
Data de Publicação: 2022
Outros Autores: Rabito, Estela Iraci, Queiroz, Christiane
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Uningá (Online)
Texto Completo: https://revista.uninga.br/uninga/article/view/4061
Resumo: Adverse effects caused by antineoplastic treatment can negatively affect the nutritional status of cancer patients. Nutritional therapy through the use of bioactive compounds may help to control the adverse effects of anticancer therapy. This study aims to identify which bioactive compounds can act as adjuvants in anticancer treatment. It is an integrative review elaborated in six stages, and it is written in accordance with PRISMA. Sixteen randomized clinical trials, obtained from the period 2003 to 2020, were included. The symptoms observed were mucositis (1 study, intervention with the use of calendula) and nausea and vomiting (15 studies with intervention with ginger). Nine studies had positive outcomes in terms of symptom relief, while in seven no statistically significant differences were found. The effectiveness of the interventions was attributed to the bioactive compounds present in marigold and ginger, especially gingerol and shogaol. There are some limitations that restricted the observations about the results obtained, such as: the lack of standardization of the content of bioactive compounds, limited number of studies and low methodological quality of some clinical trials. Due to the variability of results obtained in the studies, and low quality of evidences, the effectiveness of the use of bioactive compounds in modulating adverse symptoms caused by antineoplastic therapy is still uncertain. However, the results with the utilization of ginger seem promising, and further studies are required.
id UNINGA-1_2ed8008d15a3d63a9dd79871dded0eaa
oai_identifier_str oai:ojs.revista.uninga.br:article/4061
network_acronym_str UNINGA-1
network_name_str Revista Uningá (Online)
repository_id_str
spelling The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatmentO uso de compostos bioativos na modulação dos efeitos adversos do tratamento antineoplásicoCompostos bioativosefeitos adversostratamento antineoplásico. NutriçãoAdverse effectsantineoplastic treatmentbioactive compound.NutritionAdverse effects caused by antineoplastic treatment can negatively affect the nutritional status of cancer patients. Nutritional therapy through the use of bioactive compounds may help to control the adverse effects of anticancer therapy. This study aims to identify which bioactive compounds can act as adjuvants in anticancer treatment. It is an integrative review elaborated in six stages, and it is written in accordance with PRISMA. Sixteen randomized clinical trials, obtained from the period 2003 to 2020, were included. The symptoms observed were mucositis (1 study, intervention with the use of calendula) and nausea and vomiting (15 studies with intervention with ginger). Nine studies had positive outcomes in terms of symptom relief, while in seven no statistically significant differences were found. The effectiveness of the interventions was attributed to the bioactive compounds present in marigold and ginger, especially gingerol and shogaol. There are some limitations that restricted the observations about the results obtained, such as: the lack of standardization of the content of bioactive compounds, limited number of studies and low methodological quality of some clinical trials. Due to the variability of results obtained in the studies, and low quality of evidences, the effectiveness of the use of bioactive compounds in modulating adverse symptoms caused by antineoplastic therapy is still uncertain. However, the results with the utilization of ginger seem promising, and further studies are required.Os efeitos adversos causados pelo tratamento antineoplásico afetam negativamente o estado nutricional dos pacientes oncológicos. A terapia nutricional por meio do uso de compostos bioativos pode auxiliar no controle dos efeitos adversos da terapia antineoplásica. Este estudo tem como objetivo identificar quais compostos bioativos podem atuar como adjuvantes no tratamento antineoplásico. Trata-se de uma revisão integrativa elaborada em seis etapas e redigida segundo PRISMA. Foram incluídos 16 ensaios clínicos randomizados encontrados no período de 2003 a 2020. Os sintomas encontrados foram mucosite (1 estudo, intervenção com uso de calêndula), enquanto náusea e vômito (15 estudos com intervenção com gengibre). Nove estudos tiveram desfechos positivos quanto ao alívio dos sintomas, enquanto em sete não foram encontradas diferenças estatisticamente significativas. A eficácia das intervenções foi atribuída aos compostos bioativos presentes na calêndula e no gengibre, sobretudo o gingerol e shogaol. Há algumas limitações que restringiram as observações acerca dos resultados obtidos, como: a falta de padronização de teor de compostos bioativos, número limitado de estudos e baixa qualidade metodológica de alguns ensaios clínicos. Devido a variabilidade de resultados encontrados nos estudos e a baixa qualidade das evidências, a eficácia do uso de compostos bioativos na modulação dos sintomas adversos causados pela terapia antineoplásica ainda é incerta. No entanto, os resultados com uso de gengibre parecem promissores, sendo necessário mais estudos.Editora Uningá2022-03-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTextoinfo:eu-repo/semantics/otherapplication/pdfapplication/pdfhttps://revista.uninga.br/uninga/article/view/406110.46311/2318-0579.59.eUJ4061Revista Uningá; Vol. 59 (2022); eUJ4061Revista Uningá; v. 59 (2022); eUJ40612318-057910.46311/ru.v59ireponame:Revista Uningá (Online)instname:Centro Universitário Uningáinstacron:UNINGAporenghttps://revista.uninga.br/uninga/article/view/4061/2625https://revista.uninga.br/uninga/article/view/4061/2627Copyright (c) 2022 Revista Uningáhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Erika Klingelfus de AlmeidaRabito, Estela IraciQueiroz, Christiane2023-10-20T17:11:45Zoai:ojs.revista.uninga.br:article/4061Revistahttps://revista.uninga.br/uninga/indexPUBhttps://revista.uninga.br/uninga/oairevistauninga@uninga.edu.br2318-05792318-0579opendoar:2023-10-20T17:11:45Revista Uningá (Online) - Centro Universitário Uningáfalse
dc.title.none.fl_str_mv The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
O uso de compostos bioativos na modulação dos efeitos adversos do tratamento antineoplásico
title The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
spellingShingle The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
Silva, Erika Klingelfus de Almeida
Compostos bioativos
efeitos adversos
tratamento antineoplásico.
Nutrição
Adverse effects
antineoplastic treatment
bioactive compound.
Nutrition
title_short The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
title_full The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
title_fullStr The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
title_full_unstemmed The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
title_sort The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment
author Silva, Erika Klingelfus de Almeida
author_facet Silva, Erika Klingelfus de Almeida
Rabito, Estela Iraci
Queiroz, Christiane
author_role author
author2 Rabito, Estela Iraci
Queiroz, Christiane
author2_role author
author
dc.contributor.author.fl_str_mv Silva, Erika Klingelfus de Almeida
Rabito, Estela Iraci
Queiroz, Christiane
dc.subject.por.fl_str_mv Compostos bioativos
efeitos adversos
tratamento antineoplásico.
Nutrição
Adverse effects
antineoplastic treatment
bioactive compound.
Nutrition
topic Compostos bioativos
efeitos adversos
tratamento antineoplásico.
Nutrição
Adverse effects
antineoplastic treatment
bioactive compound.
Nutrition
description Adverse effects caused by antineoplastic treatment can negatively affect the nutritional status of cancer patients. Nutritional therapy through the use of bioactive compounds may help to control the adverse effects of anticancer therapy. This study aims to identify which bioactive compounds can act as adjuvants in anticancer treatment. It is an integrative review elaborated in six stages, and it is written in accordance with PRISMA. Sixteen randomized clinical trials, obtained from the period 2003 to 2020, were included. The symptoms observed were mucositis (1 study, intervention with the use of calendula) and nausea and vomiting (15 studies with intervention with ginger). Nine studies had positive outcomes in terms of symptom relief, while in seven no statistically significant differences were found. The effectiveness of the interventions was attributed to the bioactive compounds present in marigold and ginger, especially gingerol and shogaol. There are some limitations that restricted the observations about the results obtained, such as: the lack of standardization of the content of bioactive compounds, limited number of studies and low methodological quality of some clinical trials. Due to the variability of results obtained in the studies, and low quality of evidences, the effectiveness of the use of bioactive compounds in modulating adverse symptoms caused by antineoplastic therapy is still uncertain. However, the results with the utilization of ginger seem promising, and further studies are required.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Texto
info:eu-repo/semantics/other
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revista.uninga.br/uninga/article/view/4061
10.46311/2318-0579.59.eUJ4061
url https://revista.uninga.br/uninga/article/view/4061
identifier_str_mv 10.46311/2318-0579.59.eUJ4061
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://revista.uninga.br/uninga/article/view/4061/2625
https://revista.uninga.br/uninga/article/view/4061/2627
dc.rights.driver.fl_str_mv Copyright (c) 2022 Revista Uningá
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Revista Uningá
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Editora Uningá
publisher.none.fl_str_mv Editora Uningá
dc.source.none.fl_str_mv Revista Uningá; Vol. 59 (2022); eUJ4061
Revista Uningá; v. 59 (2022); eUJ4061
2318-0579
10.46311/ru.v59i
reponame:Revista Uningá (Online)
instname:Centro Universitário Uningá
instacron:UNINGA
instname_str Centro Universitário Uningá
instacron_str UNINGA
institution UNINGA
reponame_str Revista Uningá (Online)
collection Revista Uningá (Online)
repository.name.fl_str_mv Revista Uningá (Online) - Centro Universitário Uningá
repository.mail.fl_str_mv revistauninga@uninga.edu.br
_version_ 1797042158837956608